Message from the Chair, Ann Dozier, Ph.D.
Welcome to the Department of Public Health Sciences at the University of Rochester Medical Center. We are a welcoming, dynamic group dedicated to the improvement of health and health care among diverse populations through research, learning, and community partnerships. Our faculty members engaged in research activities across the lifespan from maternal-child health to long-term care. Our scientific inquiry uses a range of rigorous methodologies from high powered analytics to mixed methods. Our educational offerings provide multiple alternatives. These include PhD programs in Epidemiology and Health Services Research, Master's programs in Public Health, Epidemiology, Clinical Investigation, and Health Services Research, and 6 Advanced Certificates in Epidemiology, Health Services Research, Biomedical Informatics, Public Health, and Regulatory Science. I invite you to explore our website to learn more about who we are and the services we offer.
View all news »
Scott Steele, PhD, Director of the CTSI Regulatory Science Core has been selected to serve on the Food and Drug Administration's (FDA) Science Board. The Board provides advice to the Commissioner and other FDA offcials, exploring issues from gene editing or regulation of opioids to food safety, and aims to help the FDA keep pace with technical and scientific developments.
AAMC Taps URMC for National Community Health and Equity Initiative. Theresa Green, PHD, MBA, spearheaded the proposal which led to URMC being selected as just one of eight institutions chosen by the Association of American Medical Colleges to join the collaboration, which will map our community health activities, evaluate their impacts, help us share best practices and foster the development of targeted actions.
Deborah Ossip, PhD, Elected President of the Society for Research on Nicotine and Tobacco.
Todd Jusko, PhD, Assistant Professor of Epidemiology, was awarded a one year research contract from the Centers for Disease Control and Prevention. The overall objective of the project is to examine the relationship between in utero and postnatal blood lead concentrations and children's immune system function.
Robert Block, MD, MPH, was awarded a 2-year research grant from the international Atherosclerosis Society and Pfizer Pharmaceutical Corporation. The overall goal is to partner with patients with familial hypercholesterolemia (a genetic disease that causes very premature heart attacks and strokes) and physicians in order to build and test educational/motivational information about this disease within the University of Rochester's electronic health record.
Helena Temkin-Greener, PhD was awarded a two-year research grant from the Donaghue Foundation. The overall goal of the research project is to develop process and outcome-based measures of care quality for nursing home residents with mental health and behavioral disorders, and to explain variations in these measures across facilities and regions/states. Locally, findings will provide a benchmark performance measure for nursing homes participating in the NYS Delivery System Reform Incentive Payment (DSRIP) Program.